BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10226999)

  • 21. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
    Arroyo V; Terra C; Ginès P
    J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatorenal syndrome: diagnosis, treatment and prevention].
    Egerod Israelsen M; Gluud LL; Bendtsen F; Møller S; Krag AA
    Ugeskr Laeger; 2013 May; 175(22):1562-6. PubMed ID: 23721840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of refractory ascites and hepatorenal syndrome.
    Sussman AN; Boyer TD
    Curr Gastroenterol Rep; 2011 Feb; 13(1):17-25. PubMed ID: 21080246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
    Gentilini P; Laffi G; La Villa G; Raggi VC
    Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatorenal syndrome].
    Bosma JW; van Meyel JJ; Siegert CE
    Ned Tijdschr Geneeskd; 2010; 154():A1355. PubMed ID: 20456764
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of complications of hepatic cirrhosis].
    Töx U; Goeser T
    Praxis (Bern 1994); 2005 May; 94(18):727-33. PubMed ID: 15938384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome.
    Blendis L; Wong F
    Clin Med (Lond); 2003; 3(2):154-9. PubMed ID: 12737373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatorenal syndrome.
    Bataller R; Ginès P; Arroyo V; Rodés J
    Clin Liver Dis; 2000 May; 4(2):487-507. PubMed ID: 11232202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of ascites.
    Tsochatzis EA; Gerbes AL
    J Hepatol; 2017 Jul; 67(1):184-185. PubMed ID: 28119010
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hepatorenal syndrome].
    Saner F; Hertl M; Broelsch CE
    Internist (Berl); 2001 Dec; 42(12):1666-71; quiz 1672-3. PubMed ID: 11793605
    [No Abstract]   [Full Text] [Related]  

  • 32. [Approach to the patient with zirrhotic ascites--no diagnosis without a tap].
    Umgelter A
    MMW Fortschr Med; 2010 Oct; 152(42):36-8. PubMed ID: 21140951
    [No Abstract]   [Full Text] [Related]  

  • 33. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.
    Arroyo V; Ginès P; Gerbes AL; Dudley FJ; Gentilini P; Laffi G; Reynolds TB; Ring-Larsen H; Schölmerich J
    Hepatology; 1996 Jan; 23(1):164-76. PubMed ID: 8550036
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ascitic decompensation].
    Pariente A
    Gastroenterol Clin Biol; 2006; 30(6-7):870-4. PubMed ID: 16885871
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatorenal syndrome: pathophysiology and management.
    Wadei HM; Mai ML; Ahsan N; Gonwa TA
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1066-79. PubMed ID: 17699328
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Arroyo V
    Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.
    Senzolo M; Cholongitas E; Tibballs J; Burroughs A; Patch D
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1143-50. PubMed ID: 17033432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Physiopathology of refractory ascites and the hepatorenal syndrome].
    Arroyo V
    Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.